ITOVEBI
RegisteredWord Mark
•
Ownership
GI
Owner Name
Type: Organization / Corporation
Address
1 DNA Way
South San Francisco, CA 94080
Critical Dates
First Use Date
Nov 7, 2024
Filing Date
Jul 15, 2024
Registration Date
Jul 29, 2025
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for use in oncology
Mark Elements
Text Mark
ITOVEBI
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 10:47 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
ITOVEBI is a standard character mark owned by Genentech, Inc., a Delaware corporation based in South San Francisco, California. It covers pharmaceutical preparations for use in oncology in International Class 005, along with classes 006, 018, 044, 046, 051, and 052. The mark is registered on the Principal Register, with registration number 7875735 issued on July 29, 2025. No active oppositions or legal proceedings are present.
Recent Activity
The application was filed on July 15, 2024, as an intent-to-use basis, advanced through a non-final office action in August 2024 and response in October 2024, and was published for opposition on November 26, 2024. A statement of use was filed on February 10, 2025, accepted in July 2025, leading to registration on July 29, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach